Even with looming generic competition expected to take a big bite out of sales of its blockbuster Advair, respiratory drugs remain key to GlaxoSmithKline, and it continues to plow money into their ...
Plus, the 110-patient study isn't testing the drugs themselves, just the handling characteristics of the respective devices. The inhalers will be tested with placebo drugs rather than Advair or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback